Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
BriaCell Therapeutics Corp. (BCTXF)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/25/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
08/21/2023 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
07/26/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
06/30/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
04/17/2023 |
8-K
| Quarterly results |
03/29/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
03/20/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
02/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
02/10/2023 |
8-K
| Quarterly results |
01/24/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
01/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
01/18/2023 |
8-K
| Quarterly results |
01/17/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
01/10/2023 |
8-K
| Quarterly results |
01/05/2023 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/14/2022 |
10-Q
| Quarterly Report for the period ended October 31, 2022 |
12/08/2022 |
8-K
| Quarterly results |
11/30/2022 |
8-K
| Quarterly results |
11/10/2022 |
8-K
| Quarterly results |
10/27/2022 |
10-K
| Annual Report for the period ended July 31, 2022 |
10/27/2022 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits ... |
10/21/2022 |
8-K
| Quarterly results |
09/14/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
08/11/2022 |
3
| Bondarenko Jamieson (Director) has filed a Form 3 on BriaCell Therapeutics Corp. |
08/04/2022 |
8-K
| Quarterly results |
08/02/2022 |
3
| Lustig Marc (Director) has filed a Form 3 on BriaCell Therapeutics Corp. |
08/01/2022 |
3
| Del Priore Giuseppe (Chief Medical Officer) has filed a Form 3 on BriaCell Therapeutics Corp. |
08/01/2022 |
3
| Taub Rebecca (Director) has filed a Form 3 on BriaCell Therapeutics Corp. |
08/01/2022 |
3
| Lopez-Lago Miguel A. (Chief Scientific Officer) has filed a Form 3 on BriaCell Therapeutics Corp. |
08/01/2022 |
3
| Schmieg Martin E. (Director) has filed a Form 3 on BriaCell Therapeutics Corp. |
08/01/2022 |
3
| Embro-Pantalony Vaughn C. (Director) has filed a Form 3 on BriaCell Therapeutics Corp. |
|
|
|